Actively Recruiting

Age: 0 - 25Years
All Genders
NCT01050296

Molecular Analysis Of Solid Tumors

Led by St. Jude Children's Research Hospital · Updated on 2025-11-12

1000

Participants Needed

1

Research Sites

868 weeks

Total Duration

On this page

Sponsors

S

St. Jude Children's Research Hospital

Lead Sponsor

A

Alex's Lemonade Stand Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study will prospectively characterize the molecular, cellular and genetic properties of primary and metastatic neuroblastoma, osteosarcoma, retinoblastoma, Ewing sarcoma family of tumors, soft tissue sarcomas, adrenocortical tumors and liver malignancies. These cell isolates will be used for gene expression array analysis, genomic analysis by \[SNP\] single nucleotide polymorphism chip, array \[CGH\] comparative genomic hybridization and next generation sequencing, and \[TEM\] transmission electron microscopy analysis. Additionally cell lines and orthotopic xenografts will be created from the obtained tumor specimens. The specificity of TCRs will be examined by comparing paired TCR from peripheral blood and tumor infiltrating CD4+ and CD8+ T cells. Epigenetic studies will be performed looking at the methylation profile of these cells and to investigate the anti-tumor T cell response both pre- and post-PD1 inhibition.

CONDITIONS

Official Title

Molecular Analysis Of Solid Tumors

Who Can Participate

Age: 0 - 25Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Must have a suspected or known diagnosis of neuroblastoma, osteosarcoma, Ewing sarcoma family of tumor, or soft tissue sarcoma with gross disease suitable for surgery or biopsy
  • Patients with retinoblastoma who require enucleation and are not on active therapeutic or biologic protocols may enroll
  • Written informed consent must be provided within 30 days of first tissue, bone marrow, or blood sample collection
  • Patient must be treated at St. Jude Children's Research Hospital or a collaborating institution
  • Patients must be 25 years old or younger at enrollment
Not Eligible

You will not qualify if you...

  • Known positive status for Hepatitis B, Hepatitis C, or HIV infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

St. Jude Children's Research Hospital

Memphis, Tennessee, United States, 38105

Actively Recruiting

Loading map...

Research Team

S

Sara M. Federico, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here